In our efforts to model high-valent intermediates in the oxygen activation cycles of nonheme diiron enzymes such as methane monooxygenase (MMOH-Q) and ribonucleotide reductase (RNR R2-X), we have synthesized and spectroscopically characterized a series of bis(µ-oxo)diiron(III,IV) complexes, [Fe 2 (µ-O) 2 -(L) 2 ](ClO 4 ) 3 , where L is tris(2-pyridylmethyl)amine (TPA) or its ring-alkylated derivatives. We now report the crystal structure of [Fe 2 (µ-O) 2 (5-Et 3 -TPA) 2 ](ClO 4 ) 3 (2), the first example of a structurally characterized reactive iron(IV)-oxo species, which provides accurate metrical parameters for the diamond core structure proposed for this series of complexes. Complex 2 has Fe-µ-O distances of 1.805(3) Å and 1.860(3) Å, an Fe-Fe distance of 2.683(1) Å, and an Fe-µ-O-Fe angle of 94.1(1)°. The EXAFS spectrum of 2 can be fit well with a combination of four shells: 1 O at 1.82 Å, 2-3 N at 2.03 Å, 1 Fe at 2.66 Å, and 7 C at 2.87 Å. The distances obtained are in very good agreement with the crystal structure data for 2, though the coordination numbers for the first coordination sphere are underestimated. The EXAFS spectra of MMOH-Q and RNR R2-X contain features that match well with those of 2 (except for the multi-carbon shell at 2.87 Å arising from pyridyl carbons which are absent in the enzymes), suggesting that an Fe 2 (µ-O) 2 core may be a good candidate for the core structures of the enzyme intermediates. The implications of these studies are discussed.

The Wilson disease copper-transporting ATPase plays a critical role in the intracellular trafficking of copper. Mutations in this protein lead to the accumulation of a toxic level of copper in the liver, kidney, and brain followed by extensive tissue damage and death. The ATPase has a novel amino-terminal domain ( approximately 70 kDa) which contains six repeats of the copper binding motif GMTCXXC. We have expressed and characterized this domain with respect to the copper binding sites and the conformational consequences of copper binding. A detailed analysis of this domain by X-ray absorption spectroscopy (XAS) has revealed that each binding site ligates copper in the +1 oxidation state using two cysteine side chains with distorted linear geometry. Analysis of copper-induced conformational changes in the amino-terminal domain indicates that both secondary and tertiary structure changes take place upon copper binding. These copper-induced conformational changes could play an important role in the function and regulation of the ATPase in vivo. In addition to providing important insights on copper binding to the protein, these results suggest a possible mechanism of copper trafficking by the Wilson disease ATPase.

Reactions of NO and CO with Fe(II) complexes of the tripodal trithiolate ligands NS3 and PS3* yield trigonal-bipyramidal (TBP) complexes with varying redox states and reactivity patterns with respect to dissociation of the diatomic ligand. The previously reported four-coordinate [Fe(II)(NS3)](-) complex reacts irreversibly with NO gas to yield the S = 3/2 {FeNO}(7) [Fe(NS3)(NO)](-) anion, isolated as the Me(4)N(+) salt. In contrast, the reaction of NO with the species generated by the reaction of FeCl(2) with Li(3)PS3* gives a high yield of the neutral, TBP, S = 1 complex, [Fe(PS3*)(NO)], the first example of a paramagnetic {FeNO}(6) complex. X-ray crystallographic analyses show that both [Fe(NS3)(NO)](-) and [Fe(PS3*)(NO)] feature short Fe-N(NO) distances, 1.756(6) and 1.676(3) A, respectively. However, whereas [Fe(NS3)(NO)]- exhibits a distinctly bent FeNO angle and a chiral pinwheel conformation of the NS3 ligand, [Fe(PS3*)(NO)] has nearly C(3v) local symmetry and a linear FeNO unit. The S = 1 [Fe(II)(PS3)L] complexes, where L = 1-MeIm, CN(-), CO, and NO(+), exhibit a pronounced lengthening of the Fe-P distances along the series, the values being 2.101(2), 2.142(1), 2.165(7), and 2.240(1) A, respectively. This order correlates with the pi-backbonding ability of the fifth ligand L. The cyclic voltammogram of the [Fe(NS3)(NO)](-) anion shows an irreversible oxidation at +0.394 V (vs SCE), apparently with loss of NO, when scanned anodically in DMF. In contrast, [Fe(PS3*)(NO)] exhibits a reversible {FeNO}(6)/{FeNO}(7) couple at a low potential of -0.127 V. Qualitatively consistent with these electrochemical findings, DFT (PW91/STO-TZP) calculations predict a substantially lower gas-phase adiabatic ionization potential for the [Fe(PS3)(NO)](-) anion (2.06 eV) than for [Fe(NS3)(NO)](-) (2.55 eV). The greater instability of the {FeNO}(7) state with the PS3* ligand results from a stronger antibonding interaction involving the metal d(z(2)) orbital and the phosphine lone pair than the analogous orbital interaction in the NS3 case. The antibonding interaction involving the NS3 amine lone pair affords a relatively "stereochemically active" dz2 electron, the z direction being roughly along the Fe-N(NO) vector. As a result, the {FeNO}(7) unit is substantially bent. By contrast, the lack of a trans ligand in [Fe(S(t)Bu)3(NO)](-), a rare example of a tetrahedral {FeNO}(7) complex, results in a "stereochemically inactive" d(z(2)) orbital and an essentially linear FeNO unit.

No abstract

The spectroscopic properties and electronic structure of an Fe(2)(III,IV) bis-mu-oxo complex, [Fe(2)O(2)(5-Et(3)-TPA)(2)](ClO(4))(3) where 5-Et(3)-TPA = tris(5-ethyl-2-pyridylmethyl)amine, are explored to determine the molecular origins of the unique electronic and geometric features of the Fe(2)O(2) diamond core. Low-temperature magnetic circular dichroism (MCD) allows the two features in the broad absorption envelope (4000-30000 cm(-)(1)) to be resolved into 13 transitions. Their C/D ratios and transition polarizations from variable temperature-variable field MCD saturation behavior indicate that these divide into three types of electronic transitions; t(2) --> t(2) involving excitations between metal-based orbitals with pi Fe-O overlap (4000-10000 cm(-)(1)), t(2)/t(2) --> e involving excitations to metal-based orbitals with sigma Fe-O overlap (12500-17000 cm(-)(1)) and LMCT (17000-30000 cm(-)(1)) and allows transition assignments and calibration of density functional calculations. Resonance Raman profiles show the C(2)(h)() geometric distortion of the Fe(2)O(2) core results in different stretching force constants for adjacent Fe-O bonds (k(str)(Fe-O(long)) = 1.66 and k(str)(Fe-O(short)) = 2.72 mdyn/A) and a small ( approximately 20%) difference in bond strength between adjacent Fe-O bonds. The three singly occupied pi-metal-based orbitals form strong superexchange pathways which lead to the valence delocalization and the S = (3)/(2) ground state. These orbitals are key to the observed reactivity of this complex as they overlap with the substrate C-H bonding orbital in the best trajectory for hydrogen atom abstraction. The electronic structure implications of these results for the high-valent enzyme intermediates X and Q are discussed.

External stimuli responsive dual drugs carrier was synthesized with Au nanorods (NRs) as the platform. On Au NRs, single stranded DNAs were assembled using 5' thiol end. Following this, complementary DNA (cDNA) strands were hybridized. This hybridized double stranded DNA facilitated doxorubicin (Dox) intercalation into the duplexes. The cDNA designed with the 5' amine functional group assisted to tether platinum [Pt(IV)] prodrugs by establishing amide bond with the acid group at the axial ligand. The other axial acid group in Pt(IV) prodrugs was conjugated with the folic acid (FA) to target folate receptors overexpressed in the cancer cells. This targeting vehicle provided remote-controlled delivery of this high toxic cargo cocktail at the tumor site, ensuring extra specificity that can avoid acute toxicity, where release of Dox and Pt(IV) was achieved upon NIR 808 nm diode laser irradiation. The dehybridization set the Dox free to bind the cell nucleus and cellular reductants reduced Pt(IV) to yield toxic Pt(II), becoming an active drug. The in vitro and in vivo studies revealed that this external stimulus responsive combination drug delivery was significantly effective.

The effects of Terminalia catappa leaf extracts (TCE) have been widely investigated, including its antioxidative, anti-inflammatory, and antidiabetic activity, as well as its antimetastatic effects on several types of human cancer. However, no study has examined the antimetastatic potential of TCE in cervical cancer cells. This study aimed to elucidate the potential antimetastatic properties of ethanol extracts of Terminalia catappa in 12-O-tetradecanoylphorbol-13-acetate treated human cervical cancer cells and investigate the signaling pathway of this process. We demonstrated that TCE elicited very low cytotoxicity and significantly inhibited cellular migration and invasion in human HeLa and SiHa cervical cancer cells. Moreover, the gelatin zymography, reverse transcription-polymerase chain reaction (RT-PCR), and real-time PCR analysis revealed that the activity and mRNA level of matrix metalloproteinase-9 (MMP-9) were inhibited by TCE in a concentration-dependent manner.The Western blot results demonstrated that the highest concentration of TCE (100 μg/ml) reduced the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2) by 46% in the HeLa cell lines. In conclusion, it was revealed that TCE exerted antimetastatic effects on cervical cancer cells by inhibiting the expression of MMP-9 through the ERK1/2 pathway. K E Y W O R D S cervical cancer, MAPK pathway, migration, MMP-9, Terminalia catappa 1 | INTRODUCTION Cervical cancer is one of the leading causes of cancer death and the 4th most frequently occurring malignancy among women worldwide and more than 260 000 women die of cervical cancer annually. 1 Moreover, International Agency for Research on Cancer (IARC) assessed the incidence rate of cervical cancer as 19.0 women per 100 000. 2 Most patients with cervical cancer present with abnormal vaginal bleeding or a cervical mass. 3 Lesion size and pelvic node metastases are vital prognostic factors in cervical cancer. 4 The Chung-Yuan Lee and Shun-Fa Yang contributed equally to the work.

No abstract